Leucovorin and Autism: Separating Fact from Fiction

The Trump administration approved the use of leucovorin, a vitamin B derivative, as a treatment for autism based on limited and weak evidence, sparking criticism from experts who emphasize the need for more rigorous studies before such treatments are widely adopted. Despite some promising small studies, the scientific community remains cautious, highlighting the importance of controlled clinical trials and the risks of premature approval.